We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+0.99%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$8.85B
AUM Growth
-$1.07B
Cap. Flow
-$1.02B
Cap. Flow %
-11.52%
Top 10 Hldgs %
56.72%
Holding
681
New
56
Increased
52
Reduced
179
Closed
373

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.56%
2 Technology 17.09%
3 Healthcare 11.19%
4 Communication Services 9.35%
5 Financials 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GO icon
451
Grocery Outlet
GO
$1.15B
-51,565
Closed -$1.11M
GPC icon
452
Genuine Parts
GPC
$18.5B
-17,633
Closed -$2.14M
GPN icon
453
Global Payments
GPN
$24.7B
-349,089
Closed -$55M
GPRE icon
454
Green Plains
GPRE
$1.14B
-6,901
Closed -$225K
GS icon
455
Goldman Sachs
GS
$303B
-999
Closed -$378K
HAL icon
456
Halliburton
HAL
$29.4B
-10,509
Closed -$227K
HCA icon
457
HCA Healthcare
HCA
$92.9B
-720
Closed -$175K
HGV icon
458
Hilton Grand Vacations
HGV
$3.51B
-3,029
Closed -$144K
HMC icon
459
Honda
HMC
$43.3B
-20,752
Closed -$636K
HOLX
460
DELISTED
Hologic
HOLX
-12,281
Closed -$906K
HON icon
461
Honeywell
HON
$68.4B
-37,478
Closed -$7.5M
HP icon
462
Helmerich & Payne
HP
$4.35B
-3,492
Closed -$96K
HQY icon
463
HealthEquity
HQY
$8.81B
-3,577
Closed -$232K
HRL icon
464
Hormel Foods
HRL
$13.1B
-1,387
Closed -$57K
HRB icon
465
H&R Block
HRB
$6.62B
-59,803
Closed -$1.5M
HSIC icon
466
Henry Schein
HSIC
$9.86B
-7,890
Closed -$601K
HSY icon
467
Hershey
HSY
$37.5B
-10,969
Closed -$1.86M
HWM icon
468
Howmet Aerospace
HWM
$108B
-27,946
Closed -$872K
HZO icon
469
MarineMax
HZO
$1.15B
-9,076
Closed -$440K
IART icon
470
Integra LifeSciences
IART
$1.3B
-7,007
Closed -$480K
ICUI icon
471
ICU Medical
ICUI
$4.57B
-2,427
Closed -$566K
IFF icon
472
International Flavors & Fragrances
IFF
$21.5B
-516,180
Closed -$69M
IHRT icon
473
iHeartMedia
IHRT
$432M
-44,592
Closed -$1.12M
ILMN icon
474
Illumina
ILMN
$33.1B
-6,702
Closed -$2.64M
IMKTA icon
475
Ingles Markets
IMKTA
$1.61B
-39,859
Closed -$2.63M

Similar funds

Lee Ainslie's Q4 2021 Portfolio in Review

As of Q4 2021, Lee Ainslie held 681 positions worth $8.85B, down 11% from $9.92B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Lee Ainslie withdrew a net $1.02B in Q4 2021, closing 373 positions and reducing 179 holdings. Its most notable exit was Centene, an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lee Ainslie opened a new position in Rivian worth $51.8M.

  • Lee Ainslie's largest Q4 2021 buy was Rivian: 500,000 shares worth $51.8M.
  • Lee Ainslie added most to Oak Street Health, Inc. in Q4 2021, an estimated $150M increase.
  • Lee Ainslie's biggest Q4 2021 reduction was Coupang, cutting an estimated $279M.
  • Lee Ainslie fully exited Centene in Q4 2021, selling an estimated $257M.
  • Lee Ainslie's ten largest holdings make up 57% of its $8.85B portfolio in Q4 2021.
  • Lee Ainslie opened 56 new positions and closed 373 in Q4 2021.
  • Lee Ainslie's portfolio value fell 11% quarter-over-quarter to $8.85B.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.